Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial ...

Researchers have discovered a new species of the elusive 'fairy lantern' genus Thismia in a hill dipterocarp forest in ...

With three clinical precision oncology programs actively enrolling patients and critical data milestones on the horizon, we are at the ...

The increase in stock price reflects investor confidence in the company’s strategic focus on AI-driven drug development, despite the widened loss. Lantern Pharma’s Q4 2024 net loss increased ...

3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Lantern Pharma Inc ... and genomic data to streamline the drug development process.

that can be accessed by Lantern collaborators for specific needs in oncology drug development, such as prediction of certain molecular features and identification of potential cancer indications ...